Swedish obstetric thromboprophylaxis guideline: background and update
- PMID: 37551130
- DOI: 10.1080/01443615.2023.2241527
Swedish obstetric thromboprophylaxis guideline: background and update
Abstract
Risk estimation concerning venous thromboembolism (VTE) and thromboprophylaxis for those at risk is routine in pregnancy. For 20 years, Swedish obstetricians have followed a weighted-risk algorithm guideline for risk estimation, based on which patient selection, timing, duration and dosage of thromboprophylaxis are determined. This article presents the latest update, the basis for the algorithm and its application for assessing moderate- to high obstetric VTE risk, defined as equal or greater absolute risk per time unit than the antepartum risk of women with one prior VTE. The risk score is based on risk factors conferring approximately fivefold increased risk of VTE or a multiple thereof. This article also presents algorithm efficacy data and describes lifestyle advice provided to patients. In our experience, the Swedish guideline for obstetric VTE risk estimation is easy to follow. It helps identify women at high risk. The risk of under- or overtreatment is thus minimised.
Keywords: Pregnancy; guidelines; lifestyle; obstetric thromboprophylaxis; thromboembolism.
Similar articles
-
Obstetric thromboprophylaxis: the Swedish guidelines.Adv Hematol. 2011;2011:157483. doi: 10.1155/2011/157483. Epub 2011 Nov 22. Adv Hematol. 2011. PMID: 22162688 Free PMC article.
-
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761. Chest. 2008. PMID: 18574280
-
The prevention of pregnancy-related venous thromboembolism.Br J Haematol. 2015 Jan;168(2):163-74. doi: 10.1111/bjh.13159. Epub 2014 Oct 14. Br J Haematol. 2015. PMID: 25312482 Review.
-
Inpatient pharmacological thromboprophylaxis in the antepartum period: an argument for risk-based thromboprophylaxis.Am J Obstet Gynecol MFM. 2025 Mar;7(1S):101567. doi: 10.1016/j.ajogmf.2024.101567. Epub 2024 Nov 24. Am J Obstet Gynecol MFM. 2025. PMID: 39586470 Review.
-
A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE.Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231160748. doi: 10.1177/10760296231160748. Clin Appl Thromb Hemost. 2023. PMID: 36972476 Free PMC article.
Cited by
-
Beneficial health effects of ultraviolet radiation: expert review and conference report.Photochem Photobiol Sci. 2025 Jun;24(6):867-893. doi: 10.1007/s43630-025-00743-6. Epub 2025 Jun 4. Photochem Photobiol Sci. 2025. PMID: 40465176 Review.
-
Evaluating Thromboprophylaxis Strategies for High-Risk Pregnancy: A Current Perspective.Pharmaceuticals (Basel). 2024 Jun 13;17(6):773. doi: 10.3390/ph17060773. Pharmaceuticals (Basel). 2024. PMID: 38931440 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources